Pharmacological mechanisms contributing to the clinical efficacy of levosimendan

Clicks: 262
ID: 268128
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Acute decompensation of chronic heart failure is a direct life-threatening situation with short-term mortality approaching 30%. A number of maladaptive changes are amplified within the cardiovascular system during the progression of chronic heart failure that makes the decompensation phase difficult …
Reference Key
z1970cardiovascularpharmacological Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Papp Z;Csapó K;Pollesello P;Haikala H;Edes I;;
Journal Cardiovascular drug reviews
Year 1970
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/15867949
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't chronic disease pyridazines / metabolism simendan pmid:15867949 doi:10.1111/j.1527-3466.2005.tb00158.x zoltán papp kálmán csapó istván edes heart failure / drug therapy hydrazones / metabolism hydrazones / pharmacology* hydrazones / therapeutic use* pyridazines / pharmacology* pyridazines / therapeutic use* treatment outcome*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.